Table 2.
Distribution of HPV among different categories of women living with HIV in Uganda
| Variable | HPV n (%) | HPV16 n (%) | HPV18/45 n (%) | HR-HPV n (%) |
|---|---|---|---|---|
| Age Group (years) | ||||
| 15–19 | 4 (0.8%) | 1 (0.9%) | 1 (0.9%) | 3 (0.8%) |
| 20–24 | 38 (7.5%) | 8 (7.6%) | 5 (4.7%) | 32 (8.0%) |
| 25–29 | 99 (19.4%) | 16 (15.1%) | 22 (20.6%) | 81 (20.3%) |
| 30–34 | 113 (22.2%) | 24 (22.6%) | 19 (17.8%) | 96 (24.1%) |
| 35–39 | 97 (19.0%) | 25 (23.6%) | 24 (22.4%) | 68 (17.0%) |
| 40–44 | 88 (17.2%) | 18 (17.0%) | 26 (24.0%) | 64 (16.0%) |
| 45–49 | 48 (9.4%) | 8 (7.6%) | 7 (6.5%) | 35 (8.8%) |
| 50 and above | 23 (4.5%) | 6 (5.7%) | 3 (2.8%) | 20 (5.0%) |
| Duration on ART | ||||
| < 0.9 months | 13 (2.5%) | 0 (0.0%) | 4 (3.7%) | 11 (2.8%) |
| 1–4.9 years | 189 (37.1%) | 35 (33.0%) | 40 (37.4%) | 154 (38.6%) |
| ≥ 5 years | 308 (60.4%) | 71 (67.0%) | 63 (58.9%) | 234 (58.7%) |
| BMI Category | ||||
| < 18.5 | 31 (7.0%) | 7 (7.6%) | 9 (9.7%) | 21 (6.1%) |
| 18.5–24.9 | 212 (47.6%) | 46 (50.0%) | 44 (47.3%) | 167 (48.1%) |
| 25–29.9 | 136 (30.6%) | 30 (32.6%) | 28 (30.1%) | 105 (30.3%) |
| >=30 | 66 (14.8%) | 9 (9.8%) | 12 (12.9%) | 54 (15.6%) |
| ART Category | ||||
| DTG-based | 501 (98.2%) | 103 (97.2%) | 105 (98.1%) | 392 (98.3%) |
| NON-DTG based | 9 (1.8%) | 3 (2.8%) | 2 (1.9%) | 7 (1.8%) |